CTCBIO Balance Sheet Health
Financial Health criteria checks 6/6
CTCBIO has a total shareholder equity of ₩79.2B and total debt of ₩30.4B, which brings its debt-to-equity ratio to 38.4%. Its total assets and total liabilities are ₩161.2B and ₩82.0B respectively.
Key information
38.4%
Debt to equity ratio
₩30.40b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩19.59b |
| Equity | ₩79.15b |
| Total liabilities | ₩82.01b |
| Total assets | ₩161.16b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: A060590's short term assets (₩80.0B) exceed its short term liabilities (₩65.8B).
Long Term Liabilities: A060590's short term assets (₩80.0B) exceed its long term liabilities (₩16.2B).
Debt to Equity History and Analysis
Debt Level: A060590's net debt to equity ratio (13.7%) is considered satisfactory.
Reducing Debt: A060590's debt to equity ratio has reduced from 95.8% to 38.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A060590 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: A060590 has sufficient cash runway for 2.2 years if free cash flow continues to grow at historical rates of 45.5% each year.